Low-Power NIR-II Excitable Organic Phototheranostic Agents With NIR-IIb Emission for Precise Cancer Theranostics
Xin Chen , Yifan Wu , Yutao Hu , Lina Feng , Renmanduhu Sha , Guoyu Jiang , Ben Zhong Tang , Jianguo Wang
Aggregate ›› 2026, Vol. 7 ›› Issue (8) : e70422
Organic small-molecule phototheranostic agents (OPTAs) with second near-infrared (NIR-II, 1000–1700 nm) absorption show great potential for precise cancer theranostics. However, achieving simultaneous NIR-IIb (1500–1700 nm) emission and high photothermal conversion efficiency (PCE) under low-power 1064 nm excitation remains challenging due to competing radiative and nonradiative decay pathways. Herein, we report a facile molecular design strategy using noncovalent conformational locks (NoCLs) to develop efficient NIR-II excitable OPTAs with both bright NIR-IIb emission and superior PCE. Two A–D–A'–D–A type molecules (NCF and QCF) are synthesized. By introducing S···N NoCLs, QCF adopts a more planar and rigid conformation, facilitating compact J-aggregation and enhanced intramolecular charge transfer. Therefore, QCF nanoparticles (NPs) exhibit a strong NIR-II absorption at 1143 nm, dual emission at 1338/1550 nm, and a high PCE of 75% under low-power 1064 nm laser irradiation (0.3 W cm−2). Single-crystal and theoretical analyses confirm that S···N NoCLs promote planarization, suppress nonradiative decay, and strengthen intermolecular interactions. In vivo, QCF NPs enable high-resolution NIR-IIb vascular/tumor imaging and effective tumor ablation with excellent biosafety. This work establishes NoCLs as a generalizable design principle for next-generation NIR-II OPTAs with synergistic optical and therapeutic properties, advancing imaging-guided cancer theranostics.
low-power / near-infrared-II excitation / near-infrared-IIb emission / noncovalent conformational locks / photothermal therapy
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
2026 The Author(s). Aggregate published by SCUT, AIEI, and John Wiley & Sons Australia, Ltd.
/
| 〈 |
|
〉 |